MFGR1877S

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MFGR1877S, covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients With Relapsed or Refractory t(4;14)-Positive Multiple Myeloma [Phase 1]

See pricing